GlassScriptPhysician profile
Janey Nicole Sappe
NPI 1225592561
$3,706.69
in general payments reported to CMS, 2019-2025
25 companies · $462 in 2025
The $462 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,328 · 2022: $1,063 · 2023: $385 · 2024: $470 · 2025: $462.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,316.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,316.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,204.77 | 2021-2024 | Relistor |
| Abbvie INC. | $746.19 | 2021-2025 | |
| Biohaven Pharmaceuticals, INC. | $240.79 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $200.43 | 2022 | |
| Almatica Pharma LLC | $168.26 | 2021-2023 | Gralise |
| Protega Pharmaceutials INC | $160.20 | 2023-2025 | Roxybond |
| Amgen INC. | $151.26 | 2021-2022 | |
| Pfizer INC. | $120.03 | 2021-2025 | |
| Biodelivery Sciences International, INC. | $113.61 | 2021 | |
| Redhill Biopharma INC. | $81.14 | 2021 | |
| Horizon Therapeutics Plc | $79.63 | 2021-2023 | Krystexxa |
| Valinor Pharma, LLC | $55.15 | 2024-2025 | Movantik |
| Forte Bio-Pharma LLC | $53.40 | 2024 | Prolate, Nalocet |
| Si-Bone, INC. | $50.24 | 2025 | |
| Arbor Pharmaceuticals, INC. | $45.72 | 2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Virtus Pharmaceuticals LLC | $42.22 | 2021 | |
| Bioventus LLC | $34.68 | 2021 | |
| Spr Therapeutics, INC | $28.73 | 2023 | Sprint Pns System |
| Axsome Therapeutics, INC. | $26.64 | 2025 | Symbravo |
| Scilex Pharmaceuticals INC. | $18.80 | 2021 | |
| Grt US Holding, INC. | $18.03 | 2021 | |
| Allergan, INC. | $17.60 | 2021 | |
| Masimo Corporation | $17.57 | 2023 | Patient Safetynet System |
| Curonix LLC | $16.41 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Globus Medical, INC. | $15.19 | 2025 | Senza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janey Sappe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.